BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32781040)

  • 1. PKCλ/ι Loss Induces Metabolic Reprogramming in Liver Cancer: Hitting Two Birds with One Stone?
    Ramadori P; Li X; Heikenwalder M
    Cancer Cell; 2020 Aug; 38(2):152-154. PubMed ID: 32781040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression.
    Kudo Y; Sugimoto M; Arias E; Kasashima H; Cordes T; Linares JF; Duran A; Nakanishi Y; Nakanishi N; L'Hermitte A; Campos A; Senni N; Rooslid T; Roberts LR; Cuervo AM; Metallo CM; Karin M; Diaz-Meco MT; Moscat J
    Cancer Cell; 2020 Aug; 38(2):247-262.e11. PubMed ID: 32589943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.
    Linares JF; Zhang X; Martinez-Ordoñez A; Duran A; Kinoshita H; Kasashima H; Nakanishi N; Nakanishi Y; Carelli R; Cappelli L; Arias E; Yashiro M; Ohira M; Patel S; Inghirami G; Loda M; Cuervo AM; Diaz-Meco MT; Moscat J
    Mol Cell; 2021 Nov; 81(21):4509-4526.e10. PubMed ID: 34560002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase Cλ/ι in cancer: a contextual balance of time and signals.
    Moscat J; Linares JF; Duran A; Diaz-Meco MT
    Trends Cell Biol; 2022 Dec; 32(12):1023-1034. PubMed ID: 35501226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Def-6, a novel regulator of small GTPases in podocytes, acts downstream of atypical protein kinase C (aPKC) λ/ι.
    Worthmann K; Leitges M; Teng B; Sestu M; Tossidou I; Samson T; Haller H; Huber TB; Schiffer M
    Am J Pathol; 2013 Dec; 183(6):1945-1959. PubMed ID: 24096077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of mitochondrial function and cellular energy metabolism by protein kinase C-λ/ι: a novel mode of balancing pluripotency.
    Mahato B; Home P; Rajendran G; Paul A; Saha B; Ganguly A; Ray S; Roy N; Swerdlow RH; Paul S
    Stem Cells; 2014 Nov; 32(11):2880-92. PubMed ID: 25142417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCλ/ι.
    Nakanishi Y; Reina-Campos M; Nakanishi N; Llado V; Elmen L; Peterson S; Campos A; De SK; Leitges M; Ikeuchi H; Pellecchia M; Blumberg RS; Diaz-Meco MT; Moscat J
    Cell Rep; 2016 Sep; 16(12):3297-3310. PubMed ID: 27653691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKCλ/ι regulates Th17 differentiation and house dust mite-induced allergic airway inflammation.
    Yang Y; Dong P; Zhao J; Zhou W; Zhou Y; Xu Y; Mei C; Guo F; Zheng Y; Yang JQ
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):934-941. PubMed ID: 29305916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma.
    Zhou J; Zhang X; Tang H; Yu J; Zu X; Xie Z; Yang X; Hu J; Tan F; Li Q; Lei X
    Clin Chim Acta; 2020 Jul; 506():1-8. PubMed ID: 32109431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
    Kim YB; Kotani K; Ciaraldi TP; Henry RR; Kahn BB
    Diabetes; 2003 Aug; 52(8):1935-42. PubMed ID: 12882908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance and expression of atypical protein kinase C-iota in human hepatocellular carcinoma.
    Wang JM; Li Q; Du GS; Lu JX; Zou SQ
    J Surg Res; 2009 Jun; 154(1):143-9. PubMed ID: 19101699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diacylglycerol promotes GLUT4 translocation to the cell surface in a PKCε-dependent and PKCλ/ι and -ζ-independent manner.
    Tsuchiya A; Kanno T; Nishizaki T
    Life Sci; 2013 Aug; 93(5-6):240-6. PubMed ID: 23800645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C lambda/iota (PKClambda/iota): a PKC isotype essential for the development of multicellular organisms.
    Suzuki A; Akimoto K; Ohno S
    J Biochem; 2003 Jan; 133(1):9-16. PubMed ID: 12761193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma.
    Bartolini D; Dallaglio K; Torquato P; Piroddi M; Galli F
    Transl Res; 2018 Mar; 193():54-71. PubMed ID: 29274776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of interleukin receptor-associated kinase (IRAK) phosphorylation and signaling by iota protein kinase C.
    Mamidipudi V; Lin C; Seibenhener ML; Wooten MW
    J Biol Chem; 2004 Feb; 279(6):4161-5. PubMed ID: 14684752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy.
    Ichimura Y; Waguri S; Sou YS; Kageyama S; Hasegawa J; Ishimura R; Saito T; Yang Y; Kouno T; Fukutomi T; Hoshii T; Hirao A; Takagi K; Mizushima T; Motohashi H; Lee MS; Yoshimori T; Tanaka K; Yamamoto M; Komatsu M
    Mol Cell; 2013 Sep; 51(5):618-31. PubMed ID: 24011591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
    Nozaki Y; Motomura H; Tamori S; Kimura Y; Onaga C; Kanai S; Ishihara Y; Ozaki A; Hara Y; Harada Y; Mano Y; Sato T; Sato K; Sasaki K; Ishiguro H; Ohno S; Akimoto K
    PLoS One; 2020; 15(7):e0235747. PubMed ID: 32658903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
    Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma.
    Qian Y; Yao W; Yang T; Yang Y; Liu Y; Shen Q; Zhang J; Qi W; Wang J
    Hepatology; 2017 Oct; 66(4):1165-1182. PubMed ID: 28574228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
    Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
    Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.